Annotation Detail

Information
Associated Genes
KRAS
Associated Variants
KRAS Q61
KRAS Q61
Associated Disease
multiple myeloma
Source Database
CIViC Evidence
Description
In a retrospective study of 439 patients with multiple myeloma enrolled in a clinical trial, 28 had mutaions in KRAS. Those with mutations had worse overall and progression free survival than those without mutations.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/489
Gene URL
https://civic.genome.wustl.edu/links/genes/30
Variant URL
https://civic.genome.wustl.edu/links/variants/203
Rating
4
Evidence Type
Prognostic
Disease
Multiple Myeloma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
18528420
Drugs